Sort
23,748 grants matching “melanoma”
Senescence-on-a-chip: Building a microphysiological 3D skin model
$549,999Angela M Christiano · Columbia University Health Sciences · UG3 · FY2023 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$549,997Kathryn Miller-Jensen · Yale University · U01 · FY2023 · CA
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
$549,980Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
Structure-function studies of LAG3 interactions with antibodies and cellular ligands
$549,962Vincent Christopher Luca · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra
$549,873Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
NK CELLS INDUCE DCI-MEDIATED ANTI-TUMOR IMMUNITY
$549,797Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Modulating the resolution of angiogenesis and normalization of the vasculature for therapeutic benefit
$549,665Toni M. Antalis · University Of Maryland Baltimore · R01 · FY2025 · HL
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$549,649Lawrence E Flaherty · Wayne State University · UG1 · FY2024 · CA
Program control of CD8+ T cell response to tumors and tumor memory
$549,460Dorina Avram · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Southern Nevada Cancer Research Foundation--CCOP
$549,418Southern Nevada Cancer Research Fdn · U10 · FY2003 · CA
Role of circular RNA CDR1as in melanoma
$549,348Eva Hernando · New York University School Of Medicine · R01 · FY2020 · CA
Stromal Regulation of Basal Cell Carcinoma Formation
$549,316Anthony E Oro · Stanford University · R01 · FY2023 · AR
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$549,102Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$549,069Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$548,960Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The tumor ecosystem in cancer progression and immunotherapeutic response
$548,896Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
NOVEL COMBINATORIAL IMMUNO-THERAPY FOR MELANOMA
$548,874The Medical College Of Wisconsin, Inc. · · FY2014 · Department of the Army
Identification of Melanoma Susceptibility Gene at 1p22
$548,823Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2006 · CA
Developing new therapeutic strategies for brain metastasis
$548,753Eva Hernando · New York University School Of Medicine · R01 · FY2025 · CA
The Nodal Signaling Pathway In Embryonic Development
$548,685Michael Kuehn · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)
$548,672Mohamed H. Abdel-Rahman · Ohio State University · R01 · FY2022 · CA
The KIT Signaling Pathway as a Therapeutic Target in Melanoma
$548,613Boris C Bastian · Wistar Institute · P01 · FY2013 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$548,033Andrew E Aplin · Wistar Institute · P01 · FY2020 · CA
Utilization of a novel dissimilarity approach to identify a novel mechanism of Merkel cell polyomavirus small tumor antigen nuclear import responsible for the development of Merkel cell carcinoma
$547,875Kristine Nicole Dye · Stetson University · R15 · FY2025 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$547,798James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA